Skip to content

MESO

Mesoblast Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$15.13
+1.75%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
87.01x
P/S forward
126.65x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
3.46x
Price / sales
16.37x
Price / cash flow
-47.64x

Enterprise value

Enterprise value
$2.0B
EV / sales
16.57x
EV / EBITDA
-44.28x
EV / EBIT
-38.69x
Market cap
$2.0B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026